MedTrace Logo

Special Drug Use Investigation for ALLERMIST (Long Term)

NCT01420822 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2015-03-27

No results posted yet for this study

Summary

This post-marketing surveillance study is to investigate possible problems or questions in safety and efficacy of ALLERMIST Nasal Spray for long-term use in Japanese subjects with allergic rhinitis under the conditions of actual practical use.

Conditions

  • Rhinitis

Interventions

DRUG

Fluticasone

Collection of safety data

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-12-31
Primary Completion
2014-08-31
Completion
2014-08-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01420822 on ClinicalTrials.gov